Author:
Hagen Sven,Baumann Tobias,Wagner Hanna J.,Morath Volker,Kaufmann Beate,Fischer Adrian,Bergmann Stefan,Schindler Patrick,Arndt Katja M.,Müller Kristian M.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Springer, C. J. & Niculescu-Duvaz, I. Gene-directed enzyme prodrug therapy (GDEPT): choice of prodrugs. Adv. Drug Deliv. Rev. 22, 351–364 (1996).
2. Bhatia, S. et al. Innovative Approaches for Enhancing Cancer Gene Therapy. Discov. Med. 15, 309–317 (2013).
3. Erbs, P. et al. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res. 60, 3813–22 (2000).
4. Maguire, A. M. et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358, 2240–8 (2008).
5. Simonelli, F. et al. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol. Ther. 18, 643–50 (2010).
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献